(Q35172434)

6 August 2017

1 reference

title

Paraneoplastic neurological syndromes: an update on diagnosis, pathogenesis, and therapy (English)

1 reference

6 August 2017

Raymond Voltz

1

1 reference

PubMed ID

12849427

6 August 2017

language of work or name

1 reference

1 September 2002

1 reference

6 August 2017

1 reference

6 August 2017

1

1 reference

6 August 2017

294-305

1 reference

6 August 2017

5

1 reference

Lambert-Eaton Myasthenic Syndrome

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Paraneoplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Visual disturbances in advanced cancer patients: clinical observations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Cancer-associated retinopathy (CAR syndrome) with antibodies reacting with retinal, optic-nerve, and cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

The photoreceptor cell-specific nuclear receptor is an autoantigen of paraneoplastic retinopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Molecular cloning and characterization of human PTB-like protein: a possible retinal autoantigen of cancer-associated retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Tubby-like protein 1 as an autoantigen in cancer-associated retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Anti-enolase-alpha autoantibodies in cancer-associated retinopathy: epitope mapping and cytotoxicity on retinal cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Melanoma-associated retinopathy: does autoimmunity prolong survival?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

"Limbic encephalitis" and its association with carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

The Ophelia syndrome: memory loss in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Molecular and clinical diversity in paraneoplastic immunity to Ma proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Epilepsia partialis continua and frontal features as a debut of anti-Hu paraneoplastic encephalomyelitis with focal frontal encephalitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Epilepsia partialis continua: a new manifestation of anti-Hu-associated paraneoplastic encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Opsoclonus in three dimensions: oculographic, neuropathologic and modelling correlates

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Long-term neurobehavioral outcomes in children with neuroblastoma and opsoclonus-myoclonus-ataxia syndrome: relationship to MRI findings and anti-neuronal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Antineuronal Antibodies in Patients With Neuroblastoma and Paraneoplastic Opsoclonus-Myoclonus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Central alveolar hypoventilation associated with paraneoplastic brain-stem encephalitis and anti-Hu antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Chorea resulting from paraneoplastic striatal encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Ballistic-choreic movements as the presenting feature of renal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Paraneoplastic cerebellar degeneration. III. Cerebellar degeneration, cancer, and the Lambert-Eaton myasthenic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Motor neuron syndromes in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Primary sensory neuropathy with muscular changes associated with carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Utility of anti-Hu antibodies in the diagnosis of paraneoplastic sensory neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Paraneoplastic peripheral neuropathy associated with anti‐Hu antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Phenotypic and neuropathologic heterogeneity of anti-Hu antibody-related paraneoplastic syndrome presenting with progressive dysautonomia: report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Paraneoplastic gastrointestinal motor dysfunction: clinical and laboratory characteristics.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Paraproteinemic neuropathies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Carcinoma associated paraneoplastic peripheral neuropathies in patients with and without anti-onconeural antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Paraneoplastic sensorimotor neuropathy associated with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

A study on a new antineural antibody in a case of paraneoplastic sensory neuropathy associated with breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Paraneoplastic painful ulnar neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Motor neuron disease: a paraneoplastic process associated with anti-hu antibody and small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Amyotrophic lateral sclerosis and lymphoma: bone marrow examination and other diagnostic tests

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Autoimmunity to beta IV spectrin in paraneoplastic lower motor neuron syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Favourable prognosis in Lambert-Eaton myasthenic syndrome and small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Neurological paraneoplastic syndromes in patients with small cell lung cancer. A prospective survey of 150 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

P/Q-type voltage-gated calcium channel antibodies in paraneoplastic disorders of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Titin antibodies in myasthenia gravis: identification of a major immunogenic region of titin

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Paraneoplastic myasthenia gravis: detection of anti-MGT30 (titin) antibodies predicts thymic epithelial tumor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Anti-titin antibodies in myasthenia gravis: tight association with thymoma and heterogeneity of nonthymoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Do titin and cytokine antibodies in MG patients predict thymoma or thymoma recurrence?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Predicting factors of malignancy in dermatomyositis and polymyositis: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Neuromyotonia, myocloni, sensory neuropathy and cerebellar symptoms in a patient with antibodies to neuronal nucleoproteins (anti-Hu-antibodies)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Morvan's fibrillary chorea: a paraneoplastic manifestation of thymoma

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Acquired neuromyotonia and peripheral neuropathy in a patient with Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

A case of Hodgkin's lymphoma producing neuromyotonia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Autoantibodies to a 128-kd synaptic protein in three women with the stiff-man syndrome and breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Autoimmunity to gephyrin in Stiff-Man syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Neuronal antinuclear antibody in sensory neuronopathy from lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

The case for a descriptive generic nomenclature: clarification of immunostaining criteria for PCA-1, ANNA-1, and ANNA-2 autoantibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Neurologic paraneoplastic antibodies (anti-Yo; anti-Hu; anti-Ri): the case for a nomenclature based on antibody and antigen specificity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

EFNS task force report: a questionnaire-based survey on the service provision and quality assurance for determination of diagnostic autoantibody tests in European neuroimmunology centres. European Federation of Neurological Societies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Survival and outcome in 73 anti-Hu positive patients with paraneoplastic encephalomyelitis/sensory neuronopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Anti-Hu antibody titre and brain metastases before and after treatment for small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer?A quantitative western blot analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Anti-Hu immunolabeling as an index of neuronal differentiation in human brain tumors: a study of 112 central neuroepithelial neoplasms.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

The cytoplasmic Purkinje onconeural antigen cdr2 down-regulates c-Myc function: implications for neuronal and tumor cell survival

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

A post-transcriptional regulatory mechanism restricts expression of the paraneoplastic cerebellar degeneration antigen cdr2 to immune privileged tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Nova-1 regulates neuron-specific alternative splicing and is essential for neuronal viability

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Cerebellar degeneration with Hodgkin disease. An immunological study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Immunological characterization of a neuronal antibody (anti-Tr) associated with paraneoplastic cerebellar degeneration and Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Localization of the neuronal antigen recognized by anti-Tr antibodies from patients with paraneoplastic cerebellar degeneration and Hodgkin's disease in the rat nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

A reversible neuronal antibody (anti-Tr) associated paraneoplastic cerebellar degeneration in Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

A role of amphiphysin in synaptic vesicle endocytosis suggested by its binding to dynamin in nerve terminals

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Anti-amphiphysin I antibodies in patients with paraneoplastic neurological disorders associated with small cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Antiamphiphysin antibodies with small-cell lung carcinoma and paraneoplastic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Antiamphiphysin antibodies are associated with various paraneoplastic neurological syndromes and tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

New Purkinje cell antibody (PCA-2): marker of lung cancer-related neurological autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Yet another paraneoplastic antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Are the "newly discovered" paraneoplastic anticollapsin response-mediator protein 5 antibodies simply anti-CV2 antibodies?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

ANNA-3 anti-neuronal nuclear antibody: marker of lung cancer-related autoimmunity.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Paraneoplasia and autoimmunologic injury of the nervous system: the anti-Hu syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Analysis of the IgG subclass distribution and inflammatory infiltrates in patients with anti-Hu-associated paraneoplastic encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Myasthenia Gravis: Passive Transfer from Man to Mouse

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Antibodies to recoverin induce apoptosis of photoreceptor and bipolar cells in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Type IIa ('anti-Hu') antineuronal antibodies produce destruction of rat cerebellar granule neurons in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

IgG-mediated cytotoxicity to myenteric plexus cultures in patients with paraneoplastic neurological syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Nuclear localization of anti-Hu antibody is not associated with in vitro cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Paraneoplastic anti-Hu serum: studies on human tumor cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Immunization with the paraneoplastic encephalomyelitis antigen HuD does not cause neurologic disease in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 1. Mouse strains bearing different MHC molecules produce antibodies on immunization with recombinant Yo protein, but do not cause Purkinje cell loss

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Anti-Yo antibodies and cerebellar degeneration in a man with adenocarcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Immunohistochemical analysis of the immune reaction in the nervous system in paraneoplastic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Ganglionitis in paraneoplastic subacute sensory neuronopathy: a morphologic study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Inflammatory infiltrates and complete absence of Purkinje cells in anti-Yo-associated paraneoplastic cerebellar degeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Sub-acute cerebellar degeneration with anti-Yo autoantibodies: immunohistochemical analysis of the immune reaction in the central nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

T-cell receptor analysis in anti-Hu associated paraneoplastic encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Cell-mediated autoimmunity in paraneoplastic neurological syndromes with anti-Hu antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Cytotoxic T lymphocyte-mediated cell death in paraneoplastic sensory neuronopathy with anti-Hu antibody.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Tumor-specific killer cells in paraneoplastic cerebellar degeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Cytotoxic T cell activity against the peptide, AYRARALEL, from Yo protein of patients with the HLA A24 or B27 supertype and paraneoplastic cerebellar degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

[18F]fluorodeoxyglucose positron emission tomography in the diagnosis of cancer in patients with paraneoplastic neurological syndrome and anti-Hu antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

The role of [18F]fluoro-2-deoxyglucose-PET scanning in the diagnosis of paraneoplastic neurological disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Indolent anti-Hu-associated paraneoplastic sensory neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Spontaneous neurological improvement in anti-Hu associated encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Improvement of anti-Hu-associated paraneoplastic sensory neuropathy after chemoradiotherapy in a small cell lung cancer patient

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Clinical outcome of patients with anti-Hu-associated encephalomyelitis after treatment of the tumor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Advances in myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

1 reference

7 January 2021

Treatment approaches for Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Treatment of dermatomyositis and polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Neuromyotonia: autoimmune pathogenesis and response to immune modulating therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

High-Dose Intravenous Immune Globulin for Stiff-Person Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Intravenous immunoglobulins in the therapy of paraneoplastic neurological disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Therapy for paraneoplastic neurologic syndromes in six patients with protein A column immunoadsorption

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Immunological and clinical response to immunosuppressive treatment in paraneoplastic cerebellar degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

Plasmapheresis and antineoplastic treatment in CNS paraneoplastic syndromes with antineuronal autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900135-7

7 January 2021

10.1016/S1474-4422(02)00135-7

Identifiers

DOI

1 reference

release_iijktdlpmjbp5grvkp36lbgupq

6 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/iijktdlpmjbp5grvkp36lbgupq

24 November 2022

mapped directly with Wikidata item

PubMed ID

12849427

1 reference

PubMed ID

12849427